ASX Stock

At Trader Dealer we understand the importance of information. You can use our handy company information finder to get key fundamental data about any company listed on the ASX.

Simply enter the stock code or the name of the company you are interested in for ASX share price information, company size, research analyst forecast, share and financial ratios, as well as a business and financial summary.

Don’t know the ASX code of the stock you want? Just click on the letter below for a full alphabetical listing.


Enter ASX Stock Code

Bookmark Page !



View all Companies by Letters

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 


 
 

Clinuvel Pharmaceuticals Limited
Industry Group: Biotechnology / Medical Research - Biotechnology

Trade Online with Trader Dealer

Sorry, No Chart Available.

Business Summary
Clinuvel Pharmaceuticals Limited (Clinuvel) is an Australia-based company engaged in the biotechnology and medical research industry. During the fiscal year ended June 30, 2011, the principal activities of the Company were to develop its drug compound Scenesse (afamelanotide) for the treatment of a range of severe skin disorders. Clinuvel's work aims at preventing the symptoms of skin diseases related to the exposure to harmful ultraviolet (UV) radiation along with the need to repigment skin. Scenesse is a drug targeting erythropoietic protoporphyria (EPP), which is in Phase II and III trials in the United States and Europe, and has been granted orphan drug status. As of June 30, 2011, the Company had five wholly owned subsidiaries.

Financial Summary
BRIEF: For the six months ended 31 December 2011, Clinuvel Pharmaceuticals Limited's revenues decreased 72% to A$499K. Net loss increased 27% to A$6.2M. Revenues reflect a decrease in interest income, decreased reimbursements received and the absence of realized net currency gain on transactions. Higher loss was partially offset by a decrease in clinical development costs and a decrease in regulatory & toxicity costs.

Business Address


Level 14, 190 Queen Street
MELBOURNE, VIC 3000
Phone: 61-3-96604900
Fax: 61-3-96604999
http://www.clinuvel.com/

ASX Share Price Information
Current Price 1.655
Current Price Date 21/05/2012
52 Week Hi/Low 2.31 - 1.40
Avg Volume Last ten Days 0.01
ASX Company Sizing
Market Cap 51.55
Revenues 34.05
EBITDA -11.31
Net Income -11.41
Number of Employees 16
Enterprise Value 34.05
Research Analyst Forecast
Consensus Recommendation Outperform
Target Price 3.44000
LT Growth Rate -
Projected P/E -5.61017
Sales 2.05500
EPS -0.29500
Profit -
DPS 0.00000
Share Ratios
EPS -0.37577
RPS 0.07496
BV per Share 0.54007
Cash per Share 0.57597
Cashflow per Share -0.37275
Cashflow per Share 0.00000
Financial Ratios
Gross Margin -
ROE -53.27086
Price/Sales 22.64678
P/E -
P/Book 3.06445